Equity

BSF Health Sciences Absolute Return Fund

Overview

Important Information: Capital at Risk. The value of investments and the income from them can fall as well as rise and are not guaranteed. Investors may not get back the amount originally invested.

All currency hedged share classes of this fund use derivatives to hedge currency risk. The use of derivatives for a share class could pose a potential risk of contagion (also known as spill-over) to other share classes in the fund. The fund’s management company will ensure appropriate procedures are in place to minimise contagion risk to other share class. Using the drop down box directly below the name of the fund, you can view a list of all share classes in the fund – currency hedged share classes are indicated by the word “Hedged” in the name of the share class. In addition, a full list of all currency hedged share classes is available on request from the fund’s management company

To the extent the Fund undertakes securities lending to reduce costs, the Fund will receive 62.5% of the associated revenue generated and the remaining 37.5% will be received by BlackRock as the securities lending agent. As securities lending revenue sharing does not increase the costs of running the Fund, this has been excluded from the ongoing charges.

Loading

Performance

Performance

Growth of Hypothetical 10,000

View full chart

Reinvestments

This fund does not have any distributions data as of now.
This chart has been left intentionally blank as there is less than one year's performance data.
  1Y 3Y 5Y 10y Incept.
- - - - -
Target Benchmark 1 (%) - - - - -
  YTD 1m 3M 6M 1Y 3Y 5Y 10y Incept.
3.89 0.48 0.98 4.46 - - - - 6.64
Target Benchmark 1 (%) 2.38 0.48 1.43 2.88 - - - - 4.80
  From
31-Mar-2019
To
31-Mar-2020
From
31-Mar-2020
To
31-Mar-2021
From
31-Mar-2021
To
31-Mar-2022
From
31-Mar-2022
To
31-Mar-2023
From
31-Mar-2023
To
31-Mar-2024
Total Return (%)

as of Mar 31, 2024

- - - - -
Target Benchmark 1 (%)

as of Mar 31, 2024

- - - - -
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.

The figures shown relate to past performance. Past performance is not a reliable indicator of future performance. Markets could develop very differently in the future. It can help you to assess how the fund has been managed in the past

Share Class and Benchmark performance displayed in GBP, hedged share class benchmark performance is displayed in USD.

Performance is shown on a Net Asset Value (NAV) basis, with gross income reinvested where applicable. The return of your investment may increase or decrease as a result of currency fluctuations if your investment is made in a currency other than that used in the past performance calculation. Source: Blackrock

Key Facts

Key Facts

Net Assets of Fund
as of Jun 21, 2024
USD 16,232,705
Fund Inception Date
Aug 3, 2023
Base Currency
USD
Target Benchmark 1
3 Month SOFR Compounded in Arrears plus 26.1 basis point spread
Initial Charge
0.00%
ISIN
LU2353382547
Performance Fee
20.00%
Minimum Subsequent Investment
GBP 10000
Domicile
Luxembourg
Management Company
BlackRock (Luxembourg) S.A.
Dealing Settlement
Trade Date + 3 days
Bloomberg Ticker
BLSARIG
Share Class Inception Date
Aug 3, 2023
Share Class Currency
GBP
Asset Class
Equity
SFDR Classification
Other
Ongoing Charge
1.08%
Annual Management Fee
1.00%
Minimum Initial Investment
GBP 10000000
Use of Income
Accumulating
Regulatory Structure
UCITS
Morningstar Category
-
Dealing Frequency
Daily, forward pricing basis
SEDOL
BMYYH55

Portfolio Characteristics

Portfolio Characteristics

Number of Holdings
as of May 31, 2024
79
3y Beta
as of -
-
P/B Ratio
as of May 31, 2024
20.24
Standard Deviation (3y)
as of -
-
P/E Ratio
as of May 31, 2024
63.58

Sustainability Characteristics

Sustainability Characteristics

To be included in MSCI ESG Fund Ratings, 65% (or 50% for bond funds and money market funds) of the fund’s gross weight must come from securities with ESG coverage by MSCI ESG Research (certain cash positions and other asset types deemed not relevant for ESG analysis by MSCI are removed prior to calculating a fund’s gross weight; the absolute values of short positions are included but treated as uncovered), the fund’s holdings date must be less than one year old, and the fund must have at least ten securities. MSCI Ratings are currently unavailable for this fund.

Business Involvement

Business Involvement

Business Involvement metrics can help investors gain a more comprehensive view of specific activities in which a fund may be exposed through its investments.


Business Involvement metrics are not indicative of a fund’s investment objective, and, unless otherwise stated in fund documentation and included within a fund’s investment objective, do not change a fund’s investment objective or constrain the fund’s investable universe, and there is no indication that an ESG or Impact focused investment strategy or exclusionary screens will be adopted by a fund. For more information regarding a fund's investment strategy, please see the fund's prospectus.


Review the MSCI methodology behind the Business Involvement metrics, using links below.

MSCI - Controversial Weapons
as of May 31, 2024
0.00%
MSCI - Nuclear Weapons
as of May 31, 2024
0.00%
MSCI - Civilian Firearms
as of May 31, 2024
0.00%
MSCI - Tobacco
as of May 31, 2024
0.00%
MSCI - UN Global Compact Violators
as of May 31, 2024
0.00%
MSCI - Thermal Coal
as of May 31, 2024
0.00%
MSCI - Oil Sands
as of May 31, 2024
0.00%

Business Involvement Coverage
as of May 31, 2024
57.69%
Percentage of Fund not covered
as of May 31, 2024
42.55%
BlackRock business involvement exposures as shown above for Thermal Coal and Oil Sands are calculated and reported for companies that generate more than 5% of revenue from thermal coal or oil sands as defined by MSCI ESG Research. For the exposure to companies that generate any revenue from thermal coal or oil sands (at a 0% revenue threshold), as defined by MSCI ESG Research, it is as follows: Thermal Coal 0.00% and for Oil Sands 0.00%.

Business Involvement metrics are calculated by BlackRock using data from MSCI ESG Research which provides a profile of each company’s specific business involvement. BlackRock leverages this data to provide a summed up view across holdings and translates it to a fund's market value exposure to the listed Business Involvement areas above.


Business Involvement metrics are designed only to identify companies where MSCI has conducted research and identified as having involvement in the covered activity. As a result, it is possible there is additional involvement in these covered activities where MSCI does not have coverage. This information should not be used to produce comprehensive lists of companies without involvement. Business Involvement metrics are only displayed if at least 1% of the fund’s gross weight includes securities covered by MSCI ESG Research.

ESG Integration

ESG Integration

ESG integration is the practice of incorporating financially material environmental, social and governance (ESG) data or information into the investment decision process with the objective of enhancing risk-adjusted returns of our clients’ portfolios. Unless otherwise stated in Fund documentation or included within the Fund's investment objective, inclusion of this statement does not imply that the Fund has an ESG-aligned investment objective or strategy, but rather describes how ESG data or information is considered as part of the overall investment process.

The Fund manager includes ESG considerations in combination with other information in the research and decision phases of the investment process. The Fund manager conducts regular portfolio reviews between with the Risk and Quantitative Analysis group and with the Chief Investment Officers. Where appropriate, these reviews include discussion of the portfolio's exposure to material ESG risks, as well as exposure to sustainability-related business involvements, climate-related metrics, and other factors.

Ratings

Risk Indicator

Risk Indicator

1
2
3
4
5
6
7
Low Risk High Risk
Low Yield High Yield

Holdings

Holdings

as of May 31, 2024
Name Weight (%)
ELEVANCE HEALTH INC 2.88
CENCORA INC 2.28
HCA HEALTHCARE INC 2.16
COOPER INC 2.10
DANAHER CORP 2.04
Name Weight (%)
BOSTON SCIENTIFIC CORP 1.97
THERMO FISHER SCIENTIFIC INC 1.93
LONZA GROUP AG 1.82
STRYKER CORP 1.76
BLUEPRINT MEDICINES CORP 1.52
Holdings subject to change

Exposure Breakdowns

Exposure Breakdowns

as of May 31, 2024

% of Market Value

Type Fund
as of May 31, 2024

% of Market Value

Type Fund
as of May 31, 2024

% of Market Value

Type Fund
as of May 31, 2024

% of Market Value

Type Fund
Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management. Allocations are subject to change.

Pricing & Exchange

Pricing & Exchange

Investor Class Currency NAV NAV Amount Change NAV % Change NAV As Of 52wk High 52wk Low ISIN
I2 Hgd GBP 106.52 -0.33 -0.31 Jun 21, 2024 106.92 99.77 LU2353382547
I2 Hgd CHF 103.17 -0.33 -0.32 Jun 21, 2024 104.38 99.79 LU2353382620
A2 USD 106.16 -0.33 -0.31 Jun 21, 2024 106.57 99.76 LU2353382034
Class Z2 USD 107.04 -0.32 -0.30 Jun 21, 2024 107.42 99.77 LU2353382976
I2 Hgd EUR 105.28 -0.34 -0.32 Jun 21, 2024 105.89 99.75 LU2353382463
D2 USD 106.56 -0.33 -0.31 Jun 21, 2024 106.96 99.77 LU2353382208
D2 Hgd EUR 105.08 -0.33 -0.31 Jun 21, 2024 105.73 99.75 LU2575169037
A2 Hgd EUR 104.69 -0.33 -0.31 Jun 21, 2024 105.45 99.74 LU2353382117
I2 EUR 109.10 0.07 0.06 Jun 21, 2024 109.55 98.92 LU2575169110
A2 EUR 108.49 0.07 0.06 Jun 21, 2024 108.95 98.92 LU2575168906
I2 USD 106.77 -0.33 -0.31 Jun 21, 2024 107.16 99.77 LU2353382380
X2 USD 108.23 -0.33 -0.30 Jun 21, 2024 108.62 99.78 LU2353382893

Portfolio Managers

Portfolio Managers

Erin Xie, PhD
Head of the Fundamental Equities Health Sciences Team, Portfolio Manager, Managing Director

Erin Xie, PhD, Managing Director, is head of the Health Sciences team within BlackRock Fundamental Equities and lead portfolio manager for the Health Sciences equity portfolios.

Xiang Liu
Xiang Liu

Literature

Literature